piribedil has been researched along with mazindol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amalric, M; Baunez, C; Chezaubernard, C; Maurin, B; Morain, P; Nieoullon, A; Puma, C; Turle-Lorenzo, N | 1 |
1 other study(ies) available for piribedil and mazindol
Article | Year |
---|---|
The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Cognition; Corpus Striatum; Dopamine Agonists; Drug Therapy, Combination; Levodopa; Male; Mazindol; Motor Activity; Parkinson Disease; Piribedil; Rats; Rats, Wistar; Reaction Time | 2006 |